Cargando...

Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo

Treatment with PPARγ agonists in vivo improves human adipocyte metabolism, but the cellular mechanisms and possible depot differences in responsiveness to their effects are poorly understood. To examine the ex vivo metabolic effects of rosiglitazone (Rosi), we cultured explants of human visceral (om...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Lipid Res
Autores principales: Lee, Mi-Jeong, Jash, Sukanta, Jones, Jessica E. C., Puri, Vishwajeet, Fried, Susan K.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Biochemistry and Molecular Biology 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6446708/
https://ncbi.nlm.nih.gov/pubmed/30782959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M091173
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!